• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1990 Fiscal Year Final Research Report Summary

Chemosensitivity of Ovarian clear Cell Carcinoma Revealed by Disease Oriented Screening System.

Research Project

Project/Area Number 63570767
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Obstetrics and gynecology
Research InstitutionUniversity of Tsukuba

Principal Investigator

IWASAKI Hirokazu  Inst. Clin. Med., Associated Professor, 臨床医学系, 教授 (40045951)

Co-Investigator(Kenkyū-buntansha) TSUNODA Hajime  Inst. Clin. Med., Associated Professor, 臨床医学系, 講師 (60197754)
NISHIDA Masato  Inst. Clin. Med., Associated Professor, 臨床医学系, 講師 (00110875)
Project Period (FY) 1988 – 1990
KeywordsOvarian Clear Cell Carcinoma / Chemosensitivity / Disease Oriented Screening System
Research Abstract

Studies were undertaken to examine the chemosensitivity of ovarian clear cell carcinoma in vitro by MTT assay.
Four kinds of established human ovarian clear cell carcinoma cell line, HAC-2, OVAS, RMG-I and KK were used in this study.
Twenty-three kinds of antitumor agents including ADM, THP-ADM, EPI, ACR, DM, PEP, BLM, Act-D, MMC, NCS, VLB, VCR, VDS, CPM, MTX, Ara-C, 5-FU, L-ASP, CDDP, 254-S, CBDCA, NCNU, ETP were examined.
The cells were inoculated into microplate at 1 or 3x10^4/well (day 0), cultured for 3 days and exposed to each drug at 0, 0.01, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10 mic g/ml, for 1, 3, 6, 12, 24, 48, 72hs (day 3), washed free drug and incubate media alone. The enzyme activities were measured by MTT assay (day 7). The antitumor effects of each drug were evaluated from the surviving fraction curves.
As a result of this study, RMG-I had multidrug resistance and none of drugs were effective. Other 3 kinds of cell lines have similar drug sensitivities and the most effective drugs on this tumor were Act-D, CDDP and 254-S.

  • Research Products

    (2 results)

All Other

All Publications (2 results)

  • [Publications] 西田 正人: "卵巣clear cell carciuomaに対するCa培抗剤併用の化学療法をめぐって" 産科と婦人科. 57. 930-936 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M. Nishida, H. Iwasaki: "Enhancement of chemosensitivity of ovarian clear cell carcinoma with calcium antagonist." Sanka to Fujinka. 57. 930-936 (1990)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1993-08-12  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi